Showing results (1-10 of 234) with videos related to
Sort By:
Pageof 24
Oncology (Williston Park, N.Y.)|March 1, 2006
The impact of targeted therapy on the treatment of colorectal cancerJohn L Marshall, Jimmy HwangCurrent Opinion in Investigational Drugs (London, England : 2000)|January 11, 2007
Targeted therapy for colorectal cancerJimmy Hwang, John L MarshallCurrent Cancer Drug Targets|December 2, 2014
Irreversible multitargeted ErbB family inhibitors for therapy of lung and breast cancerDeepa Subramaniam, Aiwu Ruth He, Jimmy Hwang, et al.Journal of Gastrointestinal Oncology|October 18, 2016
Beyond HER2: recent advances and future directions in targeted therapies in esophagogastric cancersJimmy HwangOncotarget|December 20, 2017
Molecular characteristics of hepatocellular carcinomas from different age groupsCelina Ang, Anthony Shields, Joanne Xiu, et al.Expert Opinion on Investigational Drugs|February 16, 2011
BIBW 2992 in non-small cell lung cancerDeepa S Subramaniam, Jimmy HwangExpert Review of Anticancer Therapy|December 25, 2008
Treatment of resectable gastric cancer: current standards of carePhilip Abraham Kovoor, Jimmy HwangCurrent Treatment Options in Oncology|October 13, 2009
Treatment of metastatic colorectal cancer in the elderlyHong L Nguyen, Jimmy HwangCancer Chemotherapy and Pharmacology|March 26, 2014
A phase I study of oral ixabepilone in patients with advanced solid tumorsJohn F Deeken, John L Marshall, Michael J Pishvaian, et al.Journal of Gastrointestinal Oncology|September 3, 2013
Continuum of care with anti-angiogenic therapies in metastatic colorectal cancerBrandon G Smaglo, Jimmy HwangPageof 24